Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000

BACKGROUND: An accurate and reproducible next-generation sequencing platform is essential to identify malignancy-related abnormal DNA methylation changes and translate them into clinical applications including cancer detection, prognosis, and surveillance. However, high-quality DNA methylation seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jin, Su, Mingyang, Ma, Jianhua, Xu, Minjie, Ma, Chengcheng, Li, Wei, Liu, Rui, He, Qiye, Su, Zhixi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426093/
https://www.ncbi.nlm.nih.gov/pubmed/37582783
http://dx.doi.org/10.1186/s13148-023-01543-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426093/
https://www.ncbi.nlm.nih.gov/pubmed/37582783
http://dx.doi.org/10.1186/s13148-023-01543-4

Ejemplares similares